All lobbying filings

CORMEDIX INC.

Lobbying for CORMEDIX INC. · Biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $380,000.00 expenses · posted Jul 2, 2026

Official filing document

Bills named in this filing 4

HR 6214
Kidney Care Access Protection Act
S 2730
Kidney Care Access Protection Act
HR 7352
PASTEUR Act of 2026
S 4815
CHIP IN for Veterans Act of 2026

Lobbying activity 1

Health Issues

H.R. 6214/S. 2730, Kidney Care Access Protection Act, including provisions related to healthcare and Medicare H.R. 7352/S. 4815, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2026

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.